Old age brings with it an increased likelihood of long-term conditions, as well as the prospect of taking multiple medicines. Frailty, dementia and mobility problems all contribute to the challenges faced by healthcare services when caring for ageing populations. Much can be done to improve the lives of older people – through innovative care pathways, evidence-based medicine and research into ageing and the delivery of care. Here, you can find news stories and articles on topics ranging ...
The use of multiple medicines is still a major problem in British care homes, from the impact on residents to the strain on NHS resources, but ‘deprescribing’ can mitigate these risks.
Evidence is emerging that some dementia cases could be prevented by leading a healthy lifestyle but long-term studies are needed to confirm the strength of the association.
Devising ways to improve medicines adherenceSubscription
There are many reasons why patients do not take their medicines as prescribed. Discovering the specific cause of non-adherence is the best way to improve it.
Around 10% of older people, and almost a third of care home residents, develop a urinary tract infection each year.
Preventing falls in older peopleSubscription
How pharmacy teams can reduce the risk of falls in elderly people by identifying risk factors and managing medicines.
All too often are older patients given multi-compartment compliance aids to help them take their medicines. But these devices are not the be-all and end-all when offering support to such patients
Reducing falls among older people is a key aim of the National Service Framework for Older People. Clare Bellingham finds out how pharmacists in Barnet, Enfield and Haringey have been getting involved
Some women could live longer if they take hormone replacement therapy because of its cardiovascular protective effects, according to a new retrospective study.
Bisphosphonates are prescribed to prevent fractures in osteoporosis, but new research suggests that, paradoxically, they can also cause tiny cracks in bone
More than 40% of off-label prescriptions for antidepressants have no strong evidence for the indication, increasing risks of adverse drug events, large study shows.
There is no evidence that postmenopausal hormone replacement therapy (HRT) is associated with a decreased risk of Alzheimer’s disease or dementia, a large, 20-year follow-up study has found.
Using data from nearly 400,000 patients, researchers found that simvastatin in particular was associated with a lower risk of Alzheimer’s disease.
Researchers say benzodiazepines should only be used in the short term after study shows that they cause an increased risk of hip fracture.
Researchers say nursing homes need a more sophisticated error recording system after a meta-analysis showed that some sort of medication error had affected 16–27% of residents.
The US Food and Drug Administration (FDA) has approved dehydroepiandrosterone (DHEA) (Intrarosa; Endoceutics) for the treatment of vulvovaginal atrophy (VVA) in postmenopausal women.